Topics

Companies Related to "2019 Adult Respiratory Distress Syndrome Clinical Trials Guide" [Most Relevant Company Matches] RSS

17:58 EST 15th December 2019 | BioPortfolio

Here are the most relevant search results for "2019 Adult Respiratory Distress Syndrome Clinical Trials Guide" found in our extensive corporate database of over 50,000 company records.

Showing "2019 Adult Respiratory Distress Syndrome Clinical Trials Guide" Companies 1–25 of 6,300+

Extremely Relevant

Discovery Laboratories

Discovery Laboratories, Inc. is a specialty pharmaceutical company leveraging its platform technology in humanized lung surfactants to develop novel respiratory therapies and pulmonary drug delivery products. Surfactants are produced naturally in the lungs and are essential to the lungs' ability to absorb oxygen.Our humanized surfactant technology is being developed initially for critical care pa...


Evolutec Group plc

Evolutec discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. Evolutec has progressed its lead therapeutic molecule, rEV131, a novel histamine binding protein, from discovery to completion of initial Phase II clinical trials in allergic conjunctivitis, rhinitis and ocular inflammation. Positive preclinical data has also been generated in asthma ...

Advanced Discovries for Health

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, inflammation and oncology. Using our internal discovery capabilities and our network of pharmaceutical and academic partners, we have assembled a promising pipeline of clinical and preclinical product candidates for the treatment of respiratory tract inf...


Relevant

Vapotherm, Inc.

Vapotherm, Inc. is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 1.7 million patients have been treated with Vapotherm Hi-VNI Techn...

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and cancer. X4’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. X4’s most advanced product candidate, X4P-001, is in a Ph...

Advanced Life Sciences Holding

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, inflammation and oncology. Using our internal discovery capabilities and our network of pharmaceutical and academic partners, we have assembled a promising pipeline of clinical and preclinical product candidates for the treatment of respiratory tract inf...

Stemedica Cell Technologies Inc.

Stemedica Cell Technologies Inc. is a specialty biopharmaceutical company that is committed to the manufacturing and development of best-in-class, allogeneic, adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and clinical (human) trials. The company is a government-licensed manufacturer of clini...

Cell Therapy Foundation

The Cell Therapy Foundation is a not-for-profit organization committed to advancing the treatment of disease using adult stem cells. Emerging as a leader in raising funds for adult stem cell research, Cell Therapy Foundation strives to increase awareness about adult stem cells, to fund adult stem cell research addressing several specific diseases, and to accelerate the rate of research and clini...

Novaliq GmbH

"Novaliq GmbH is a medical technology / biopharmaceutical company with the aim to develop and market life-saving drug delivery systems for the treatment of severe lung diseases, such as for example acute respiratory distress syndrome (ARDS). The so-called semifluorinated alkanes (SFA) used for this purpose can equally be developed and used as carrier fluid or aerosol for the transport of pharmaceu...

Respiratory Motion, Inc.

ExSpiron continuously and noninvasively measures and displays lung volume against time, generating quantitative metrics for minute ventilation (the amount of air that enters/leaves the lungs every minute), respiratory rate (breaths per minute), and tidal volume (the volume of air in a single breath). Minute ventilation was previously only captured continuo...

Research Down Syndrome

Research Down Syndrome (RDS) is a non-profit foundation which funds research at leading institutions directed towards identifying safe and effective biomedical therapies to treat the intellectual difficulties associated with Down syndrome. RDS' mission is to educate and inspire society to fund and support Down syndrome cognitive research to enhance and expand life opportunities, helping people wit...

Sjogren's Syndrome Foundation

Founded in 1983, the Sjogren's Syndrome Foundation (SSF) provides patients with practical information and coping strategies that minimize the effects of Sjogren's syndrome. In addition, the Foundation is the clearinghouse for medical information and is the recognized national advocate for Sjogren's syndrome. The Foundation's mission is to educate patients and their families about Sjogren's syndrom...

Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has developed a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(TM)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that inc...

ALung Technologies, Inc.

ALung Technologies, Inc. is commercializing artificial lung devices for the treatment of acute and chronic respiratory disorders. The company's Hemolung System, designed to replace or supplement the use of ventilators for patients with acute respiratory failure, is scheduled to begin clinical trials in the fall of 2009. Learn more about ALung and Hemolung at www.alung.com.

Verified Clinical Trials, LLC

Verified Clinical Trials (VCT) was developed by experts active in the clinical research community to proactively improve clinical research participant safety and data quality in clinical research trials. Verified Clinical Trials defines itself as the world's leader in the field of database registries in clinical trial research, and is the only clinical res...

The International Rett Syndrome Foundation

While there are over 3,800 known cases of Rett Syndrome in the United States which predominantly strikes only girls, the disorder is genetically linked to more widespread neurological disorders such as autism and schizophrenia. Rett symptoms begin to manifest between the first six to eighteen months of life and in most cases will eventually incapacitate the afflicted children so that they can...

High Point Clinical Trials Center

High Point Clinical Trials Center is a leading clinical research unit focused on the conduct of early stage clinical pharmacology and POC Studies for biotechnology and pharmaceutical companies worldwide. The dedicated trials facility specializes in the execution of Phase I-III clinical trials.

West Coast Clinical Trials, LLC

West Coast Clinical Trials, LLC is a thriving research practice with an active adult and pediatric unit. The corporate office is located in Costa Mesa which also houses a 30 bed unit. Our second office is a 25,000 square foot facility located in Long Beach, California. We specialize in allergy, asthma, hypertension, diabetes, cholesterol, dermatology, COPD, upper respiratory studies, pediatric and...

ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (www.ert.com) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. It is also a leading provider of centrali...

Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Our clinical focus is on Parkinson's disease and pain. We were established in 1999 as a spin-off from Pharmacia & Upjohn and are headquartered in Bresso, near Milan, Italy. We are conducting Phase III c...

GRAYLINE CLINICAL DRUG TRIALS

Founded in 1986, Grayline Clinical Drug Trials is a full-service contract research site dedicated to providing clinical trials management and support to pharmaceutical companies for Phase I – IV clinical trials under FDA review. Today, Grayline is recognized as a premiere clinical trials research facility. The company and its staff bring to each clinical trial project a formidable body of experi...

Society for Clinical Trials

The Society for Clinical Trials, created in 1978, is an international professional organization dedicated to the development and dissemination of knowledge about the design, conduct and analysis of government and industry-sponsored clinical trials and related health care research methodologies.To provide a forum for discussion of biometrical, computational, philosophical, ethical, and procedural i...

Sristek

Data is critical. And it should be managed right, especially, for clinical trials, which is a tedious and time consuming process. Even the most minute aspects demand proven expertise and innovation in order to generate the most accurate results and analysis. In such a scenario, why not get the expert brains to manage it for you. Get Sristek into your business.Sristek is the mindware for complete d...

Akebia Therapeutics, Inc.

Akebia Therapeutics is a discovery and development company focused on anemia and vascular disorders. Akebia’s lead program, AKB-6548, an orally bioavailable HIF-prolyl hydroxylase (HIF-PH) inhibitor for patients with anemia, is in phase 2 clinical trials. AKB-6548 potentially promises to be a safer, less expensive, orally dosed pharmaceutical to stimu...

Pulmatrix, Inc.

Pulmatrix, Inc., is a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases. Pulmatrix’s lead proprietary therapies, called inhaled cationic airway lining modulators (iCALM™), are a novel approach to prevent and treat acute exacerbations an...


More From BioPortfolio on "2019 Adult Respiratory Distress Syndrome Clinical Trials Guide"

Quick Search

Corporate Database Quicklinks